Products
Our Products
HLS in Canada is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties.
Product PipelineFor Canadian Residents looking to access commercial product information, please click on the product name in the table below |
||||
|---|---|---|---|---|
| CARDIOVASCULAR (CV) | ||||
| Vascepa | CV risk reduction | Canada | Marketed | |
| Trinomia | CV risk reduction | Canada | Under review | |
| CENTRAL NERVOUS SYSTEM (CNS) | ||||
| Clozaril | Schizophrenia | U.S./Canada | Marketed | |
| CSAN Pronto | WBC Point-of-Care Testing | Canada | Marketed | |
| PERSERIS | Schizophrenia | Canada | Approved and in pre-launch phase | |
| MyCare Psychiatry | Psychiatric Therapeutic Drug Monitoring | Canada | Marketed | |
| ROYALTY PRODUCTS | ||||
| Royalty Portfolio | Multiple Indications | Global | Marketed by third parties | |
For U.S. Residents, click on the American flag above for more commercial product information.